FRI0508 the Effect of Certolizumab Pegol on Extra-Articular Manifestations of Psoriatic Arthritis Over 4 Years of Treatment in Patients With and Without Prior Anti-TNF Exposure

doi 10.1136/annrheumdis-2017-eular.1969
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Extra Articular Manifestations in Egyptian Rheumatoid Arthritis Patients

Egyptian Journal of Rheumatology and Clinical Immunology
2014English

Certolizumab Pegol in the Treatment of Axial Spondyloarthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2015English

AB0745 Subclinical Atherosclerosis Evolution in Psoriatic Arthritis Patients Treated With Anti-TNF Alpha: 5 Years Follow Up

2017English

Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Original Paper Autoimmunogenicity During Anti-TNF Therapy in Patients With Psoriasis and Psoriatic Arthritis

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2015English

Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

Certolizumab Pegol for the Treatment of Crohn’s Disease

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Prevalence of Extra-Articular Manifestations in Patients of Ankylosing Spondylitis

Journal of Evidence Based Medicine and Healthcare
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy